The role of cornulin (CRNN) in the progression of cutaneous squamous cell carcinoma involving AKT activation in SCL-1
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308243 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Changji Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Skin Neoplasms, Proto-Oncogene Proteins c-akt, Carcinoma, Squamous Cell, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer that has been on the rise in recent times, particularly among older individuals. Cornulin (CRNN) is increasingly recognized as an oncogene involved in developing various types of tumors. However, the precise contribution to cSCC remains unclear. Our study observed a significant increase in CRNN expression in cSCC samples compared to healthy skin. CRNN expression in the SCL-1 cell line derived from cSCC was reduced, leading to a halt in cell growth during the transition from the G1 phase to the S phase. This reduction inhibits cell division, promotes cell death, and decreases cell invasion and migration. CRNN overexpression has been found to enhance cell growth and prevent cells from undergoing natural cell death, and the cancer-promoting effects of CRNN are linked to AKT activation. Using a mouse xenograft model, we demonstrated that the inhibition of CRNN led to a decline in cSCC tumor growth in a living organism, providing evidence of CRNN’s involvement in cSCC occurrence and development. This study establishes a foundation for evaluating the effectiveness of CRNN in treating cSCC, enabling further investigation in this area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Dermatology, Shanghai General Hospital Jiuquan Hospital (Jiuquan City People's Hospital), Jiuquan, Gansu, China.
- Department of Dermatology, the First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Dermatology, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
- Department of Dermatology, Xi'an Hospital of Traditional Chinese Medicine, Xi'an, China.
ORCID-Profile: Changji Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, C., Yang, P., Wang, X., Li, H., Jing, H., Zheng, Y., & Hou, Y. (2024). The role of cornulin (CRNN) in the progression of cutaneous squamous cell carcinoma involving AKT activation in SCL-1. PLOS ONE. https://doi.org/10.1371/journal.pone.0308243
Vancouver
Li C, Yang P, Wang X, Li H, Jing H, Zheng Y, et al. The role of cornulin (CRNN) in the progression of cutaneous squamous cell carcinoma involving AKT activation in SCL-1. PLOS ONE. 2024. doi:10.1371/journal.pone.0308243
BibTeX
@article{Li2024,
author = {Li, Changji and Yang, Peiwen and Wang, Xin and Li, Hongbao and Jing, Huiling and Zheng, Yan and Hou, Yuzhu},
title = {The role of cornulin (CRNN) in the progression of cutaneous squamous cell carcinoma involving AKT activation in SCL-1},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308243}
}
EUVIMED